As the first Medtronic self-expanding TAVR system approved in China, the Evolut PRO system approval is based on clinical data from more than 32,000 patients, which showed high survival ...

Anteris Technologies' DurAVR system expected to capture 4%-5% of the U.S. TAVR market by 2030, driven by strong clinician preference for BEV Analyst forecasts DurAVR's superior hemodynamics ...

That was again due to increased adoption of the Evolut FX+ TAVR system, the PulseSelect Pulsed Field Ablation, and Coronary products. Medtronic's Neuroscience segment generated nearly $2.5 billion ...

The firm's analysis highlighted the potential market impact of Anteris's DurAVR valve system, which is anticipated to become the second balloon-expandable transcatheter aortic valve replacement (TAVR) ...

Barclays noted the strong preference clinicians have shown for balloon-expandable TAVR systems over self-expanding alternatives offered by competitors. The DurAVR valve system, which utilizes ...

Jan. 15, 2025 — New observational data and simulation models have confirmed a new type of planet unlike anything found in the Solar System. This provides another piece of the puzzle to ...

New Delhi: Global medical device maker Abbott has introduced the Navitor Vision in India, a state-of-the-art valve technology for treating symptomatic severe aortic stenosis in patients who face ...

Last year also saw Abbott take steps forward with a new addition to its cardiac catalog, completing the first patient procedures with an upcoming balloon-expandable TAVR system for aortic stenosis.

Witthaya Prasongsin / Getty Images Foreign exchange (FX) traders are always looking for trends and economic outlooks that may help them to predict the potential movement of currencies. Some ...